From the Organizing Partner of Psychedelic Science 2023, comes The Kentucky Summit on Exploring Breakthrough Therapeutic Potential for Opioid Use Disorder, a significant event bringing together practitioners, researchers, policy makers, caregivers, and members of the community. Taking place in November in La Grange, Kentucky, this conference aims to address the pressing issues surrounding opioid use disorder (OUD) and delve into innovative therapeutic approaches to combat this crisis. Participants can expect thought-provoking discussions on evidence-based treatments, cutting-edge research, and effective policy strategies to address the complexities of OUD.
Expert speakers will present breakthrough therapeutic potentials, including novel medications, psychotherapeutic interventions, harm reduction initiatives, and community-based support systems. With a diverse range of stakeholders in attendance, the conference seeks to foster a comprehensive understanding of the challenges faced by individuals and communities affected by OUD, encouraging collaborative efforts towards a compassionate and effective response.
What is Ibogaine?
Ibogaine, a naturally occurring psychoactive compound found in plants that offers hope in reversing neurological damage caused by Opioid Use Disorder (OUD). Backed by clinical research, Ibogaine holds the potential to not only address physical dependencies but also create profound spiritually restorative moments for individuals seeking recovery. This unique substance has shown promise in restoring personal autonomy, paving the way for individuals to regain control over their lives. Experience a holistic approach to healing through Ibogaine—a beacon of possibility for those on the path to recovery.
Free Community Screening of “Of Night and Light: The Story of Iboga and Ibogaine”
Following the conclusion of the summit at 5:00pm, attendees are cordially invited to return at 6:30pm for an exclusive sneak peek community screening of ‘Of Night and Light: The Story of Iboga and Ibogaine’ from renowned documentarian Lucy Walker, followed by a stimulating Q&A discussion.
The screening is open to all registered attendees, courtesy of the event organizer, Momentum PBC, at no additional charge. Join us for this captivating exploration at a pivotal intersection of science and human experience.
About The Film:
Of Night and Light: The Story of Iboga and Ibogaine tells the astounding unknown story of what might be the scientific discovery of our generation. Back in 1962, a teenage psychonaut in New York City named Howard Lotsof experimented with an obscure psychedelic from the root bark of a West African shrub and recognized its unique therapeutic potential. Together with his African-American wife Norma, a pair of outsider NYU film students, they dedicated their lives to convincing the scientific community and government agencies to research it, certain that it would be of great medicinal benefit, despite it sounding too good to be true – like the textbook definition of snake oil – and being written off as con artists.
Sixty years later, their dream is now materializing as clinics spawned from their original test sites have treated more than 100,000 people with opiate use disorder and now over 1,000 US Special Forces veterans, who have experienced dramatic relief from a spectrum of problems including traumatic brain injury, depression, anxiety, ptsd, addictions, and physical disabilities through the use of ibogaine. Now jaw-dropping new research, about to be published, is revealing that ibogaine is the most powerful therapeutic ever observed for the human central nervous system.
Of Night and Light: The Story of Iboga and Ibogaine is directed by two-time Oscar nominated and Emmy Award-winning filmmaker Lucy Walker (Waste Land, The Crash Reel, Bring Your Own Brigade, How to Change Your Mind) and produced by Walker, Julian Cautherley, Lyn Davis Lear and Laurie Benenson.
Summit Mission Statement
The mission statement of the summit is to foster collaboration among practitioners, healthcare providers, treatment centers, caregivers, policy makers, life sciences companies, and community members to collectively strive to explore new avenues of treatment and forge a path towards a brighter and healthier future for those affected by opioid use disorder.
With Kentucky tragically grappling with fatal overdose rates, where more than 9,000 individuals have lost their lives to drug overdoses since 2018, there is a pressing need to explore innovative solutions. Many state officials recognize the potential of ibogaine as a therapeutic option to combat addiction and wish to invest in its clinical exploration. This summit promises to be a beacon of knowledge and hope, providing attendees with cutting-edge scientific, clinical, and policy updates concerning ibogaine and its potential in treating opioid use disorder. Moreover, it offers a platform for those who have experienced healing, either as recipients or providers of these treatments, to share their inspiring stories with the community.
Doc is no one. He is Banksy’s erudite elder brother, a Deadpool wannabe, and the Shadow of the world’s most interesting man. When artificial intelligence has a fever dream, it dreams of being Doc. He is a son, brother, husband, father, veteran, psycho, therapist, and friend. He is the grinning embodiment of the Duchenne marker, all of his lies are true, and he writes his books with tears in his eyes for you and only you.
Ben Askins has an eclectic background with degrees in Outdoor Education, Intercultural Studies, Physician Assistant Studies, and Divinity. He has nearly two decades of experience practicing and teaching wilderness, tactical, and expeditionary medicine in the military. In civilian life, he is a Psychiatric Physician Assistant with an evidence-focused and integrative approach to mental health that includes extensive experience providing ketamine-assisted psychotherapy, medicine management, and spiritual direction. He is certified with the Multidisciplinary Association on Psychedelic Studies (MAPS) in MDMA-assisted psychotherapy. Ben is a member of the Wilderness Medical Society, the William Blake Society, a National Outdoor Leadership school alum, a veteran of the Global War on Terrorism, and has completed postgraduate training in Neuropsychiatry and Genomics.
Benjamin Greenzweig is a seasoned events veteran, entrepreneur, and the founder of Momentum Events with a deep passion for destigmatizing the conversation on both the diagnosis and treatment of mental health, including psychedelic-assisted therapy. Greenzweig served as the Executive Producer of Psychedelic Science 2023, the world’s largest psychedelics conference, and Momentum proudly played the role of show organizer. Open about his personal wellness journey, Greenzweig passionately believes that everyone has the right to find their mental health balance, and he works tirelessly to create learning and community-building opportunities that can open minds and change hearts.
Deborah Mash is a neuroscientist, inventor, and one of the world’s foremost experts on the anti-addiction drug ibogaine. She is the CEO and Founder of DemeRx Inc., a clinical stage drug development company advancing ibogaine and its active metabolite noribogaine for the treatment of opioid use disorder. DemeRx has partnered with ATAI Life Sciences — a global biotech platform with a special focus on psychedelic medicine — to develop ibogaine for those suffering from opioid use disorder. Building on the extensive human data available around ibogaine, DemeRx and atai will submit Clinical Trial Applications for a Phase II study in opioid-dependent patients. This joint venture will develop screening procedures, dosing guidelines, and best practices for treating opioid use disorder following detoxification to ensure patient safety.
Cipriana Quann, commonly known as the “Quann Sisters” along with her identical twin sister has been using her platform to speak on diversity, inclusivity, the power of sisterhood and surviving over a decade of sexual, physical and mental childhood abuse.
Originally from Baltimore, Maryland, Cipriana was selected as one of six brilliant women in New York by Vogue Magazine for their ‘My Life in Vogue’ Documentary along with an editorial feature in the US issue of Vogue Magazine, shot by iconic Photographers Inez and Vindooh. Dubbed the “voice of your generation” by HBO, “Influential Millennial” by Gap and described as the “greatest hope for our civilization” by the great, late, legendary New York Times photographer; Bill Cunningham. Cipriana has paved her way in the fashion industry proving beauty is more than aesthetics.
Cofounder and Editor in Chief of past lifestyle website, “Urban Bush Babes”. The uniting core of the site was created to support, encourage and highlight the multi-faceted lives of women of color. Celebrating difference as the norm, and breaking down the “ideal standard” of beauty, ‘Urban Bush Babes’ quickly rose to garner a following of 450,000 weekly readers in just a year after it’s inception in 2011, and why Cipriana was 1 of 4 women around the world to be chosen for iconic Finnish Design House; Marimekko’s Women of Influence Series- an initiative highlighting women across the globe making a difference. Cipriana was the only woman selected in the United States. Marissa Mayer (President and CEO of Yahoo) was the prior US selectee.
In 2015, Cipriana was personally invited to the White House to meet current President, Joe Biden, specifically regarding her contributions of creating change within the fashion/beauty industry for women of color with her website, Urban Bush Babes.
Featured in editorial spreads of Vogue Magazine, Vanity Fair, Harper’s Bazaar, Elle, Elle Brazil, NY Mag, V Mag, Cosmopolitan and dubbed “Style Stars” by W Magazine, countless “Best Dressed” lists by Vogue Magazine, Harper’s Bazaar, US Weekly and WWD. Also named one of the ’50 Most Interesting People on the Internet’ by Cosmopolitan.
Cipriana is also a TED X Talks Speaker, featured in campaigns such as FENDI, Valentino, Tiffany & Co and Bulgari to name a few, as well as on the covers of Condé Nast Traveller, Time Out NY and IRK Magazine.
In addition Cipriana along with her sister are the first two Black American sisters to grace the cover of Harper’s Bazaar Netherlands, on the power of sisterhood and their advocacy and work to create a more inclusive fashion/beauty industry.
Cipriana has also been an ambassador for The Girls Club of New York, The Boys Club of New York and currently the ambassador and mentor for “The Riley’s Way Foundation. The foundation empowers young students to use kindness and empathy to create meaningful connections and positive change through programs that address pressing equity issues, social/justice matters, epidemiology, health, environmental/community, mental health or simply building resources within their school, locally or global areas.
Cipriana’s notoriety in the fashion world has been overshadowed by her vulnerability and courageousness to speak on the severe trauma she experienced from the age of five to fifteen years old, the debilitating effects, such as addiction that resulted from the abuse, the power of her connection as a twin sister to survive, and sustainable healing/therapeutic modalities such as passionately working with psychedelics for the past seven years.
In addition to her viral social media content along with her sister on abuse and trauma garnering over 1.5 million views. Her most recent interview with The Cut Magazine delved into her past, as she spoke on the power of her connection as a twin to survive and overcome the abusive adversaries.
Cipriana is transitioning the silence of the trauma as a child to utilize her voice as an adult, to help others seek paths of healing, de-shed the shame, guilt, fear, anger and addictions often stemmed from childhood abuse without support.
Srinivas Rao is the Chief Scientific Officer at atai Life Sciences AG. Dr. Rao
has over 19 years of professional experience in the pharmaceutical and
biotechnology industries. Prior to atai, Dr. Rao has held the titles of Chief
Scientific, Medical, or Executive Officer at companies ranging from venture
backed startups to vertically-integrated, publicly traded pharmaceutical
Dr. Rao completed an internship in Internal Medicine at Yale-New Haven
Hospital. He received his Ph.D. in neurobiology from Yale Graduate School
and his M.D. from Yale School of Medicine. He holds both a Bachelor of
Science and Master of Science degree in Electrical Engineering from Yale
College and Yale Graduate School, respectively.
Kerry Rhodes, is a former NFL-All Pro football player, who played for the NY Jets and Arizona Cardinals. He’s since transitioned to the entertainment world and is now a successful actor, producer, writer, and musician. In that transition there were hard times. Times where the feeling of aloneness and depression started to take over. Along that journey he’s found healing for himself through alternative methods, such as ayahuasca and found that sitting with that medicine changed his life forever for the better. Helped him to evolve to be the best man he can and to be a champion of compassion, for not only him but for his fellow man. His mission in life is to lead with love and to create safe spaces for others dealing with suppressed trauma and depression to live their lives fully with gratitude. He believes we all deserve that life and it’s available.
Who Should Attend
- Primary Care And Other Physicians
- Addiction Counselors
- Social Workers
- Medical Educators
- Public Health Researchers
- Faith Based Leaders And Supporters
- Veterans And First Responders
- Indigenous Community Leaders
- Family Members
- Other Behavioral Health And Wellness Stakeholders
MOMENTUM COMMUNITIES PBC, A PUBLIC BENEFIT CORPORATION
Momentum Communities PBC (dba Momentum PBC) is deeply committed to the psychedelic community and is incorporated as a Public Benefit Corporation, focusing on generating social and public good while operating in a responsible and sustainable manner.
Our mission is to empower, educate, and inspire our global community to embrace a lifestyle of wellness and healing. Through authentic storytelling, insightful content, and a commitment to scientific integrity, we aim to demystify the world of health and wellness. Our goal is to be the leading resource for individuals seeking balance, healing, and a better understanding of their own wellness journeys, nurturing a culture of well-being and conscious living for all.
In fulfilling this mission, we are committed to honoring the cultures, traditions, and reformers who have helped pave the way for this community. We recognize the rich history and diverse perspectives that exist within the psychedelic space and seek to create a platform that respects and celebrates these contributions. Through dedicated content and community building opportunities, we aim to foster an inclusive and supportive environment that welcomes individuals from all backgrounds to come together, learn from one another, and work towards a brighter future for the psychedelic movement.
Empowerment: We believe in the power of healing and wellness as a transformative process that enables individuals to reclaim their lives and thrive.
Education: We commit to providing state-of-the-art, evidence-based content, along with vibrant community-building opportunities. These offerings will cater to the diverse needs of society. We will achieve this by merging independently researched content from third-party sources with activities that foster community building and social networking.
Community: We cherish the vibrant tapestry of our existing mental health community, recognizing the strength in our diversity and unity. As we continue to foster this sense of belonging, we warmly extend our hand to those yet to join us, knowing that every voice enriches our collective journey towards healing and wellness.
Advocacy: We are committed to fostering environments that promote mental wellness, providing tools and resources that encourage holistic well-being
Compassion: Our approach is rooted in empathy, respect, and understanding, treating every individual with the dignity they deserve